Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Assembly Biosciences (ASMB) Return on Sales (2017 - 2025)

Assembly Biosciences (ASMB) has 9 years of Return on Sales data on record, last reported at 0.85% in Q3 2025.

  • For Q3 2025, Return on Sales rose 55.0% year-over-year to 0.85%; the TTM value through Sep 2025 reached 1.04%, up 40.0%, while the annual FY2024 figure was 1.41%, 714.0% up from the prior year.
  • Return on Sales reached 0.85% in Q3 2025 per ASMB's latest filing, up from 1.06% in the prior quarter.
  • Across five years, Return on Sales topped out at 2.52% in Q2 2021 and bottomed at 28.25% in Q1 2021.
  • Average Return on Sales over 5 years is 7.22%, with a median of 1.47% recorded in 2023.
  • The widest YoY moves for Return on Sales: up 774bps in 2022, down -2317bps in 2022.
  • A 5-year view of Return on Sales shows it stood at 21.17% in 2021, then increased by 2bps to 20.65% in 2022, then surged by 93bps to 1.53% in 2023, then rose by 8bps to 1.4% in 2024, then skyrocketed by 39bps to 0.85% in 2025.
  • Per Business Quant database, its latest 3 readings for Return on Sales were 0.85% in Q3 2025, 1.06% in Q2 2025, and 0.94% in Q1 2025.